Back to Agenda
Session 3: EMA Service of Medical Literature Monitoring for Reports of Suspected Adverse Drug Reactions
Session Chair(s)
Sabine Brosch, PharmD, PhD, MPharm
Data Protection Officer, European Medicines Agency, Netherlands
Margaret Anne Walters
Deputy EU Qualified Person for Pharmacovigilance, Merck, Sharp & Dohme Ltd, United Kingdom
This session will focus on the recently launched medical literature monitoring service including the impact of the EMA medical literature service on the NCAs’ and pharmaceutical companies’ business processes and experience to date.
Speaker(s)
How the Service Works and Experience to Date
Tom Paternoster-Howe, MSc
Scientific Administrator, Data Analytics & Methods, Task Force, Healthcare Data, European Medicines Agency, Netherlands
Industry Experience and Feedback
Murielle Musset, PhD
Literature Surveillance Team Lead (Pharmacovigilance), Sanofi, France
Have an account?